Backed by a robust track record in venture capital, the fund manager brings extensive experience in early-stage investments, primarily within the technology and healthcare sectors. Active across North America and Europe, they have successfully executed over 30 deals, demonstrating a strong thematic focus on digital innovation and life sciences. Notable exits include several high-profile acquisitions, showcasing a strategic style that emphasizes data-driven decision-making and operator-first principles. Their ability to identify and nurture disruptive companies positions them as a formidable player in the investment landscape.